UK’s CMA Issues Fines Over Fludrocortisone
Amilco, Aspen And Tiofarma Named In UK Investigation
Executive Summary
The UK’s Competition and Markets Authority has issued fines of nearly £2.3m after formally concluding that three firms participated in illegal arrangements over fludrocortisone that violated competition law.